期刊文献+

Ⅱ型糖尿病肾病患者血清IL-18、TNF-α、NO与ET的水平变化及临床意义 被引量:14

原文传递
导出
摘要 目的:观察2型糖尿病肾病患者(DN)血清中白细胞介素18(IL-18)、肿瘤坏死因子α(TNF-α)、一氧化氮(NO)与内皮素(ET)的水平及其临床意义。方法:将93例2型糖尿病(DM)患者分为单纯糖尿病组(SDM)患者组(31例)、隐性糖尿病肾病(IDN)患者组(30例)及显性糖尿病肾病(ODN)患者组(32例)。同时将30例健康体检者作为正常对照组。取上述各组的血清标本,用ELISA法检测IL-18和TNF-α的水平;用硝酸还原酶法检测NO的水平;用放射免疫分析法检测ET的水平。结果:与正常对照组相比较,IL-18、TNF-α与ET水平SDM患者组、IDN组患者组、ODN患者组明显升高(P<0.01),升高的水平依次为ODM患者组>IDN组患者组>SDN患者组;血清NO的水平明显降低(P<0.01),降低的水平依次为ODM患者组<IDN组患者组<SDN患者组。IL-18与TNF-α和ET均呈正相关(r值分别为0.613和0.738);ET与TNF-α也呈正相关(r值为0.649);NO与IL-18、TNF-α及ET呈负相关(r值分别为0.631和0.627及0.714)。结论:血清IL-18、TNF-α、NO与ET水平的变化,提示它们可能参与了2型DN的发病及病理变化过程,检测血清IL-18、TNF-α、NO与ET的水平可作为判断患者的预后、指导治疗的参考指标。
机构地区 解放军 解放军
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第11期1243-1244,共2页 Chinese Journal of Cellular and Molecular Immunology
  • 相关文献

参考文献8

  • 1Doherty RO, Stein D, Foley J, et al. Insulin resistance [ J ]. Diabetologia, 1997, 40: B10-13.
  • 2Esfandiari E, Mclnnes IB, Lindop G. A proinflammatory role of IL-18 in the development of spontaneous autoinmune disease [J ]. J Immunol, 2001, 167(9) : 5338 -5340.
  • 3Mahmoud RA, el-Ezz SA, Hegazy SA. Increased serum levels of interleukin-18 in patients with diabetic nephropathy [ J]. Ital J Biochem, 2004, 53(2) : 73 -76.
  • 4陈益民,许志良,袁新旺,俞颖.2型糖尿病患者血清IL-6、TNF的变化[J].浙江中西医结合杂志,2004,14(3):150-151. 被引量:13
  • 5刘颖慧,李红.TNF-α与糖尿病肾病[J].国外医学(内分泌学分册),2002,22(4):253-256. 被引量:43
  • 6Kohan DE. Endothelins in the normal and diseased kidney[J]. Am J Kidney Dis, 1997, 29 : 2 -26.
  • 7王转锁,李凤良,宋钦华.一氧化氮与糖尿病肾病的研究[J].医学综述,2004,10(9):560-562. 被引量:7
  • 8Dal SM, Shah ZZ, Nishioka K, et al. Association of interleukin-18 expression with enhanced levels of both interleukin-1 beta and tumor necrosis effect on chondrocytes may not be pivotal [ J]. Ann Rheum Dis, 2005, 64(5): 735-742.

二级参考文献45

  • 1King AJ, Brenner BM. Endothelium-derived vasoactive factors and the renal vasculature[ J]. Am J Physiol, 1991,260(4 Pt 2) : R653-662.
  • 2Kone BC. Nitric oxide in renal health and disease[J]. Am J Kidney Dis, 1997,30(3) :311-333.
  • 3Nathan C. Nitric oxide as a secretory product of mammalian cells[J].FASEB J, 1992,6(12) :3051-3064.
  • 4Moncada S, Higgs A. The L-arginine-nitric oxide pathway[ J ], N Engl J Med, 1993,329(27) :2002-2012.
  • 5Craven PA, DeRubertis FR, Melhem M. Nitric oxide in diabetic nephropathy[ J]. Kidney Int Suppl, 1997,60[ Suppl ] : S46-53,.
  • 6Bank N,Aynedjian HS. Role of EDRF (nitric oxide) in diabetic renal hwoerfiltration [ J ]. Kidney Int, 1993,43 (6) : 1306-1312.
  • 7Tolins JP, Shuhz PJ, Raij L, et al, Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO[ J ]. Am J Physiol, 1993,265 (6 Pt 2) : F886-895.
  • 8Wu G. Nitric oxide synthesis and the effect of aminoguanidine and NGmonomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat[J]. Diabetes, 1995,44(3) :360-364.
  • 9Trachtman H, Futterweit S, Singhal P. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells[J]. Bioehem Biophys Res Commun, 1995,207( 1 ) : 120-125.
  • 10Trachtman H, Futterweit S, Garg P, et al. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured mt mesangial cells[J]. Biochem Biophys Res Commun, 1996,218 (3) : 704-708.

共引文献57

同被引文献171

引证文献14

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部